We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$29.4B
AUM Growth
-$873M
Cap. Flow
+$534M
Cap. Flow %
1.81%
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$244M
2
ENPH icon
Enphase Energy
ENPH
+$229M
3
GSK icon
GSK
GSK
+$223M
4
ACN icon
Accenture
ACN
+$209M
5
C icon
Citigroup
C
+$209M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 13.67%
3 Financials 9.64%
4 Industrials 8.71%
5 Consumer Discretionary 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNTC icon
2376
Benitec Biopharma
BNTC
$468M
$14K ﹤0.01%
+2,285
New +$29K
DRUG
2377
Bright Minds Biosciences
DRUG
$778M
$14K ﹤0.01%
+2,214
New +$14.4K
EJH icon
2378
E-Home Household Service Holdings
EJH
$4M
0
TLPH icon
2379
Talphera
TLPH
$74.2M
$14K ﹤0.01%
+3,267
New +$17.1K
VATE icon
2380
INNOVATE Corp
VATE
$165M
$14K ﹤0.01%
+2,059
New +$31.5K
SMTS
2381
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$14K ﹤0.01%
29,146
-1,600
-5% -$918
PHIO icon
2382
Phio Pharmaceuticals
PHIO
$12.1M
$13K ﹤0.01%
215
-42
-16% -$3.18K
TRVN
2383
DELISTED
Trevena, Inc.
TRVN
$13K ﹤0.01%
141
+65
+86% +$9.97K
LABP
2384
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$13K ﹤0.01%
1,942
-2,704
-58% -$23.5K
ANY icon
2385
Sphere 3D
ANY
$16M
$12K ﹤0.01%
395
-2,271
-85% -$103K
NMAD
2386
Nomad Power Solutions
NMAD
$65.8M
$12K ﹤0.01%
2,127
+432
+25% +$3.22K
OTRK
2387
DELISTED
Ontrak
OTRK
$12K ﹤0.01%
289
-481
-62% -$33.7K
RVSN icon
2388
Rail Vision
RVSN
$10.4M
$12K ﹤0.01%
82
-103
-56% -$21.1K
JXG
2389
JX Luxventure
JXG
$96M
$12K ﹤0.01%
+23
New +$16.4K
GMBL
2390
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
$12K ﹤0.01%
3
-2
-40% -$31.4K
AMPE
2391
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$12K ﹤0.01%
661
+445
+206% +$15.6K
APRE icon
2392
Aprea Therapeutics
APRE
$8.05M
$11K ﹤0.01%
842
-2,177
-72% -$38.6K
KALA icon
2393
KALA BIO
KALA
$14.5M
$11K ﹤0.01%
21
+4
+24% +$3.14K
PLX icon
2394
Protalix BioTherapeutics
PLX
$198M
$11K ﹤0.01%
10,351
-15,159
-59% -$16.8K
AFIB
2395
DELISTED
Acutus Medical Inc
AFIB
$11K ﹤0.01%
+12,108
New +$14.7K
QTNT
2396
DELISTED
Quotient Limited Ordinary Shares
QTNT
$11K ﹤0.01%
1,810
+1,557
+615% +$14K
FAMI icon
2397
Farmmi Inc
FAMI
$6.01M
$10K ﹤0.01%
181
-56
-24% -$5.17K
ACOR
2398
DELISTED
Acorda Therapeutics
ACOR
$9K ﹤0.01%
+1,425
New +$11.9K
PALI icon
2399
Palisade Bio
PALI
$367M
$8K ﹤0.01%
+107
New +$22.7K
GPUS
2400
Hyperscale Data Inc
GPUS
$55.4M
0

Similar funds

Two Sigma Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Two Sigma Investments held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

Two Sigma Investments's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
  • Two Sigma Investments added most to GSK in Q3 2022, an estimated $223M increase.
  • Two Sigma Investments's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
  • Two Sigma Investments fully exited Bank of America in Q3 2022, selling an estimated $225M.
  • Two Sigma Investments's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
  • Two Sigma Investments opened 582 new positions and closed 600 in Q3 2022.
  • Two Sigma Investments's portfolio value fell 2.9% quarter-over-quarter to $29.4B.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.